首页> 外文期刊>Hepato-gastroenterology. >Prognostic accuracy of staging systems in patients with primary liver cancer undergoing transarterial chemoembolization
【24h】

Prognostic accuracy of staging systems in patients with primary liver cancer undergoing transarterial chemoembolization

机译:原发性肝癌经动脉化疗栓塞的分期系统的预后准确性

获取原文
获取原文并翻译 | 示例
           

摘要

Background/Aims: To compare the performance of the Child-Turcotte-Pugh (CTP), the Okuda, the Cancer of Liver Italian Program (CLIP), the Barcelona Clinic Liver Cancer (BCLC), the Chinese staging (CS), Chinese university prognostic index (CUPI), Japan integrated staging (JIS), the Tokyo and the French staging systems, in predicting the survival of patients with primary liver cancer (PLC) receiving transarterial chemoembolization (TACE). Methodology: The clinical data of patients undergoing TACE in our department were retrospectively analyzed and compared with the 9 staging systems based on survival after TACE. Results: A cohort of 60 patients was involved. The survival curves showed that Okuda, BCLC, CS and JIS had better discriminatory ability. By the Cox regression model, Okuda, CS and JIS showed a stronger significance on prognosis. The staging systems with smaller value of -2Ln(L), Akaike Information criterion (AIC) and Schwarz-Bayesian criterion (SBC) were CS, JIS, CLIP and BCLC. An analysis involving 11 factors by Cox model indicated that ascites and vascular invasion were independent prognostic factors. Conclusions: JIS provides better prognostic stratification for a cohort of the patients with PLC receiving TACE. However, studies with larger samples are still required.
机译:背景/目的:比较儿童Turcotte-Pugh(CTP),Okuda,意大利肝癌计划(CLIP),巴塞罗那临床肝癌(BCLC),中国分期(CS),中国大学的表现预后指数(CUPI),日本综合分期(JIS),东京和法国分期系统在预测接受经动脉化疗栓塞(TACE)的原发性肝癌(PLC)患者的生存率方面。方法:回顾性分析我科接受TACE治疗的患者的临床资料,并与9种基于TACE生存率的分期系统进行比较。结果:纳入了60名患者。存活曲线表明,奥田,BCLC,CS和JIS具有更好的判别能力。通过Cox回归模型,Okuda,CS和JIS对预后具有更强的意义。值为-2Ln(L),Akaike信息准则(AIC)和Schwarz-Bayesian准则(SBC)较小的分级系统为CS,JIS,CLIP和BCLC。 Cox模型对11个因素的分析表明,腹水和血管浸润是独立的预后因素。结论:JIS为一组接受TACE的PLC患者提供了更好的预后分层。但是,仍然需要对较大样本进行研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号